QR-Code

Ribociclib-induced acute kidney injury in patients with advanced-stage breast cancer: A case series and literature review

Introduction: The phase-3 MONALEESA-2, -3 and -7 randomized trials showed benefit of CDK4/6 inhibitor, ribociclib, in women with advanced-stage breast cancer. However, ribociclib-induced acute kidney injury (AKI) was not addressed in these studies. In this report, we explore AKI in breast cancer pat...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Maissoune Hajir, Ramiz Abu-Hijlih, Areej Abu Sheikha, Kholoud Alqasem, Hikmat Abdel-Razeq
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2023-09-01
Schriftenreihe:Current Problems in Cancer: Case Reports
Schlagworte:
Breast cancer
Ribociclib
Acute kidney injury
AKI
Endocrine therapy
CDK4/6 inhibitors
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2666621923000273
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge